Proposal for ROCR Approval
1. Record
Type?
Review
2. Unique
Number
R00156
3. Title
Radiotherapy Dataset version 5
4. Collection
Type
National
5. Other
Reference
RTDS
6. Description
RTDS forms a standardised dataset for NHS patients
receiving radiotherapy. To ensure that the RTDS offers
a complete record of radiotherapy delivered to
patients with cancer, for commissioning, business
planning and cancer registration purposes.
7. State
Resubmitted to Sponsor
8. ROCR
Reference No
ROCR/OR/2191/FT6/001MAND SCCI0111
9. Start Date
01/04/2016
10. End Date
31/03/2020
11. FT
Collection
Type
MANDATORY
12. Collection
Type
MANDATORY
13. Owning
Organisation
Public Health England
Proposal for ROCR Approval
14. Owning
Department
National Disease Registration
15. Owner
Name and
Contact
Details
Name: Stephen Raynor
Email: Stephen.raynor@phe.gov.uk
Tel No: 0203 682 0716
Location: Skipton House 80 London Road, Elephant &
Castle, London, SE1 6LH
16. Senior
Supporting
Official Name
Dr Jem Rashbass
17. Senior
Supporting
Official
Contact
Details
Title: Dr Jem Rashbass, Director National Disease
Registration
Tel No: 07796 315426
Email: jem.rashbass@phe.gov.uk
Location: PHE HQ, Wellington House, 133-155
Waterloo Road, London, SE1 8UG
18. Data
Provider Burden Days
2900
18. Data
Provider Burden £
£ 900184.6
18. Frequency
Monthly
18. Source
Organisations
(Number of
Acute Foundation Trust (50)
Proposal for ROCR Approval
orgs)
19. Set Up
Costs
£ 248321
20. Other
Costs
£ 160767.5
21. Total
Costs
£ 1309273.1
22. Please
explain the
reason for any
increase or
decrease in
burden and
provide
details of the
any other
costs figure
provided in
Q20
This application is to change the destination of where
data are transmitted to. The data extraction and
submission costs for organisations remain at the same
level there is no increase in costs. Set up Costs relate
to the costs PHE incurs in establishing the
infrastructure and resources for the service. Other
costs express the recurrent costs of PHE in collecting
analysing and reporting on RTDS. Additionally from a
provider point of view PHE will not charge £1000 per
organisation to access a reporting microsite (see 24
below).
23. Benefits to
Patients and
the NHS
The original programme for the collection of
radiotherapy data was commissioned by the National
Cancer Intelligence Network (NCIN), now part of
Public Health England (PHE). The transition to PHE has
brought together the National Cancer Registration
Service which already manages the Cancer Outcomes
and Services Dataset and the national Systemic Anti
Cancer Therapy Dataset under the Disease
Registration Division, within the Chief Knowledge
Officer's Directorate in PHE. Additionally, all former
cancer analytical resources from the old cancer
registries have been brought under the Chief
Knowledge Officer's ambit within the Knowledge and
Intelligence Teams. It follows that, along with the
Systemic Anti-Cancer Therapy dataset (SACT), the
RTDS should be brought into the National Cancer
Proposal for ROCR Approval
Registration Service within the Disease Registration
Division, as an additional data repository in order to
centralise data collection for cancer therapies and
provide the programme with the extensive support
available within PHE. It is a logical step which will see
the programme benefit from centralised data quality
and data capture systems across 160 providers of
cancer care, reducing the number of resources
required to deliver data across the NCRS yet
increasing the yield in the data collected and the
efficiency in its management. The benefits of the
collection will allow outcomes analysis on all of the
diagnostic and treatment events in a patient's cancer
pathway which will inform service planning, delivery
and commisioning for outcomes.
24. Financial
benefits to
running this
collection
NatCanSat the current organisation collecting the data
charges £1000 per RT site to access their reporting
microsite. PHE would provide an equivalent service
free of charge thereby saving organisations,
collectively up to £50,000 per annum. There is an
overall reduction in the costs to PHE of bringing the
service in-house of around £142k over 5 years. (see
22 above)
25.
Publication
methods
Web site & PHE publications gateway
26.
Publication
Links
www.gov.uk/phe
27.
Requesting
Organisation
Public Health England
28. Collection
Method
Extract from existing NHS systems
Proposal for ROCR Approval
29. NHS
Mandate
Commitment
Improving Outcomes: A Strategy for Cancer and A
Framework for Cancer Intelligence Gateway Reference
16920
30. Changes
since last
assessment
The organisation collecting and managing the data has
changed from NatCanSat to Public Health England.
31. Data in
operational
systems
Yes
32. Plans for
collecting this
data from
operational
systems
33. If the data
was not
collected,
what would
the
consequences
be
It would be impossible to identify the cost and
effectiveness of the use of radiotherapy in England.
NHS England would not be able to monitor QIPP
relating to Breast and Bone metastases and other
service specifications of national commissioning. The
cancer registry's statutory obligations and cancer
outcomes analysis would be at risk.
34. Is there an
impact
assessment or
business case
for this
collection? If
so please
attach
Yes
35. Process
required for
others to go
through to
Data will be made available for legitimate service
providers and commisisoners freely in addition to
standard reports. However, all requests for explicitly
identifiable and potentially identifiable data held by
Proposal for ROCR Approval
obtain the
data
PHE need to be made in writing to the Office for Data
Release by email to ODR@phe.gov.uk Requests may
be made by the applicant directly or via a receiving
office. Data requests should be accompanied by a
completed ODR form and supporting documents (such
as study protocol, data specification and data
management procedures) which outline the rationale
for the data request, specific data fields, and expected
timescales. PHE will only provide access to identifiable
or potentially identifiable data where there is an
acceptable legal gateway, for example Section 251.
The ODR meets weekly to decide the outcome of data
requests. Where possible, the applicant will be
informed of one of three outcomes within 2 weeks of
receiving the initial request.
36. Keywords
Radiotherapy, Cancer, Linear Accelerator
37. National /
Official
statistic
National
38. Method
used to store
the data
Original data submission files will generally be stored
on NCRS file servers, with file encryption passwords in
a secure keystore to which only authorised NCRS
administrators have access. Where NCRS provides a
file submission service, the uploaded files will be
encrypted with public/private key encryption, before
they are retrieved and moved to the NCRS file servers.
The files are eventually processed and loaded into
database tables, as part of the NCRS database.
Original data submission files will generally be stored
on NCRS file servers, with file encryption passwords in
a secure keystore to which only authorised NCRS
administrators have access. Where NCRS provides a
file submission service, the uploaded files will be
encrypted with public/private key encryption, before
they are retrieved and moved to the NCRS file servers.
The files are eventually processed and loaded into
database tables, as part of the NCRS database.
Proposal for ROCR Approval
39. Why
sampling is
not used
The purpose of the standard is to have a complete
record of all radiotherapy undertaken in England. This
is essential for the purposes of commissioning and
cancer registration.
40. Details of
any pilots
PHE is working with pilot Radiotherapy providers to
understand the technical demands of obtaining and
redirecting the data extracts to PHE. The sites being
consulted are: Guy's and St Thomas' NHS Trust
Imperial College Hospital NHS Trust The Norfolk and
Norwich NHS Trust Leeds Teaching Hospitals NHS
Trust Many more sites will be contacted and worked
with during 2015/16
41. Equalities
dimensions
used in the
collection
Age/Date of Birth, Gender, Ethnicity (NHS standard 16
+ 1)
42. Policy that
the collection
supports
The detail of the national radiotherapy programme and
in support of understanding radiotherapy can be found
at http://www.ncat.nhs.uk/our-work/ensuring-bettertreatment/radiotherapy Improving Outcomes: A
Strategy for Cancer (2011) sets out that  "Access to
radiotherapy is critical to improving outcomes and, to
improve outcomes from radiotherapy, there must be
equitable access to high quality, safe, timely, protocoldriven quality-controlled services focused around
patients’ needs”.  Detailed modelling suggests that
52% of cancer patients should receive radiotherapy as
part of their treatment. In 2007, it was estimated than
only 37% of cancer patients accessed this treatment.
While radiotherapy capacity has increased, the
demand has not increased at the rate previously
predicted and there remain variations in activity
across the country.
43. IG Data
type
Patient identifiable